Feng Li

Qingdao University — China

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

61h-index15.2kcitations480works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(34), Drug Transport and Resistance Mechanisms(33), Liver Disease Diagnosis and Treatment(24), Lung Cancer Treatments and Mutations(21), Drug-Induced Hepatotoxicity and Protection(17)

Publications480 total

The research progress of LACC1
Frontiers in Immunology·2025Open Access
Clinical application and potential benefits of En-bloc biopsy based on minimally invasive surgery in advanced lung cancer
Clinical Surgical Oncology·2025Open Access
Metabolism, Pharmacokinetics, and Tissue Distribution of a Selective FK506-Binding Protein 12 F36V Mutant Degrader in Mice
ACS Pharmacology & Translational Science·2025Open Access
Phytoconstituents as therapeutic agents in combating methotrexate-induced hepatotoxicity and nephrotoxicity
Expert Opinion on Drug Metabolism & Toxicology·2025
Risk-stratified classification of pulmonary nodule malignancy via a machine learning model integrating imaging and cell-free DNA: a model development and validation study (DECIPHER-NODL)
The Lancet Regional Health - Western Pacific·2025Open Access
Salvage of necrotic flap following malignant peripheral nerve sheath tumor excision using multimodal pharmacotherapy: a case report
Frontiers in Oncology·2025Open Access
Two-Stage Multi-View Graph Spectural Clustering for Single-Cell RNASeq Data
Current Genomics·2025· 1 cited
Isolinderalactone regulates macrophage polarization and efferocytosis by activating the LXRα pathway against ulcerative colitis
Chinese Medicine·2025Open Access
P3.01.33 Global Trends in Tracheal, Bronchus, Lung Cancer Burden From Household Air Pollution
Journal of Thoracic Oncology·2025
Development and Characterization of CLYM116, a Novel Fc-Engineered Anti-APRIL Monoclonal Antibody (mAb) with pH-Dependent Binding for IgAN
Journal of the American Society of Nephrology·2025
1589eP Immune rechallenge as second-line treatment after first-line immunotherapy failure in advanced gastric cancer: A single-center real-world study
Annals of Oncology·2025
C9orf72/SMCR8 complex maintains microglial homeostasis via RAB8A-ESCRT-mediated lysosomal repair
2025Open Access
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
The Lancet Diabetes & Endocrinology·2025· 3 cited
Osteoclasts in osteoradionecrosis: Pathogenic mechanisms and emerging therapies
Bone·2025· 2 cited
Low-dose metformin requires brain Rap1 for its antidiabetic action
Science Advances·2025· 4 citedOpen Access
Exosome circ-CBLB promotes M1 macrophage polarization in rheumatoid arthritis through the TLR3/TRAF3 signaling axis
Frontiers in Immunology·2025· 4 citedOpen Access
Mechanistic study of pexidartinib-induced toxicity in human hepatic cells
Chemico-Biological Interactions·2025· 2 citedOpen Access
172P Final analysis of a randomized, double blind, phase II study of sorafenib with or without YIV-906 in patients with advanced HCC
Annals of Oncology·2025Open Access
DiTAGInt: A Diffusion-Based Transformer Network with Augmented-Graph Embedding Integration for Cross-Domain Sequential Recommendation
2025
Characterizing the metabolites of the tyrosine-kinase inhibitor pexidartinib in mouse feces, urine, plasma, and liver
Journal of Pharmaceutical and Biomedical Analysis·2025Open Access
page 1 of 24Next →

Frequent Co-authors

Xiaochao Ma(5), Gunnar K. Gouras(4), Reisuke H. Takahashi(3), Shuai Wang(3), Yanke Lin(3), Baojian Wu(3), Hartmut Jaeschke(3), M. Flint Beal(2), Huaxi Xu(2), Paul Greengard(2), Yihan Wang(2), Lois Parillon(2), Qihong Xu(2), Xiaotian Zhu(2), David C. Dalgarno(2), William C. Shakespeare(2), Yuanquan Song(2), Cláudia G. Almeida(2), Michael T. Lin(2), Jianwei Chen(2)